New drugs developed in Korea aiming at U. S. markets.

Local pharmaceutical companies are trying to enter the U. S. markets with new drugs developed in Korea through appropriate clinical studies for the FDA approval.

Starting with Factive, developed by LG Life Science, other new drugs are exploring to enter the U. S. markets. Factive, a new anti-bacterial drug, was firstly approved by the U. S. FDA in 2003, and Beltropin, a human growth hormone,...